±«ÓãÖ±²¥

Event

Management of Disease Modifying Interventions in Alzheimer's

Tuesday, December 3, 2024 13:00to16:15
de Grandpre Communications Centre

Management of Disease Modifying Interventions in Alzheimer'sÌý


To attend in person, register hereÌý(link coming soon)


Suzanne Schindler, MD, PhD

Department of Neurology, Washington University School of Medicine

°Õ²¹±ô°ì:ÌýBiomarkers for Detection of AD and Indications of Anti-Amyloid Therapy

Abstract: TBD


Alireza Atri, MD, PhD

Department of Neurology, Harvard Medical School

°Õ²¹±ô°ì:ÌýAmyloid Related Imaging Abnormalities (ARIA)

Abstract: TBD

Ìý

Programme

Tuesday, December 3, 2024

13:00

Welcome &ÌýOpening Remarks

Pedro Rosa-Neto, MD, PhD

14:00

Biomarkers for Detection of AD and Indications of Anti-Amyloid Therapy

Suzanne Schindler, MD, PhD

14:45 Refreshment Pause
15:15

Amyloid Related Imaging Abnormalities (ARIA)

Alireza Atri, MD, PhD

16:00

Closing Remarks

Pedro Rosa-Neto, MD, PhD

16:15 Cocktail & Networking

Sponsors

Logo for Eisai

Logo for Lilly

Logo for Roche

Organizing Committee

Pedro Rosa-Neto
Director, Translational Neuroimaging Laboratory, Douglas Research Centre

Debbie Rashcovsky
Neuro Events Team Lead

Back to top